Gustavo Alfredo Ortiz, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Keratitis, Herpetic | 3 | 2022 | 85 | 1.170 |
Why?
|
alpha 1-Antitrypsin | 2 | 2018 | 178 | 1.130 |
Why?
|
Serine Proteinase Inhibitors | 2 | 2018 | 186 | 1.090 |
Why?
|
Lacrimal Apparatus | 3 | 2021 | 217 | 0.920 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 3 | 2021 | 273 | 0.900 |
Why?
|
Microscopy, Video | 1 | 2020 | 258 | 0.770 |
Why?
|
Dendritic Cells | 6 | 2021 | 2731 | 0.730 |
Why?
|
Diabetic Retinopathy | 3 | 2018 | 1210 | 0.700 |
Why?
|
Dry Eye Syndromes | 2 | 2020 | 378 | 0.700 |
Why?
|
Foramen Ovale, Patent | 1 | 2017 | 212 | 0.510 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2018 | 1234 | 0.490 |
Why?
|
Cornea | 6 | 2021 | 1468 | 0.480 |
Why?
|
Stroke | 7 | 2017 | 9510 | 0.450 |
Why?
|
Propylthiouracil | 1 | 2011 | 69 | 0.450 |
Why?
|
Antithyroid Agents | 1 | 2011 | 75 | 0.440 |
Why?
|
Cell Movement | 3 | 2020 | 5465 | 0.400 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2010 | 37 | 0.390 |
Why?
|
Antiphospholipid Syndrome | 1 | 2011 | 177 | 0.380 |
Why?
|
Herpes Zoster Oticus | 1 | 2008 | 8 | 0.350 |
Why?
|
Retina | 3 | 2020 | 2651 | 0.340 |
Why?
|
Corneal Transplantation | 3 | 2021 | 379 | 0.340 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2008 | 43 | 0.330 |
Why?
|
Cerebral Arteries | 2 | 2012 | 501 | 0.300 |
Why?
|
Brain Infarction | 1 | 2008 | 304 | 0.280 |
Why?
|
Inflammation | 5 | 2023 | 10116 | 0.240 |
Why?
|
Brain Stem | 1 | 2008 | 840 | 0.230 |
Why?
|
Graves Disease | 2 | 2016 | 249 | 0.230 |
Why?
|
Tears | 2 | 2021 | 259 | 0.230 |
Why?
|
alpha-MSH | 1 | 2021 | 63 | 0.220 |
Why?
|
Oxytocics | 1 | 2021 | 59 | 0.210 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2022 | 149 | 0.210 |
Why?
|
Type C Phospholipases | 1 | 2021 | 298 | 0.210 |
Why?
|
Brain Ischemia | 2 | 2013 | 3309 | 0.200 |
Why?
|
Autoimmune Diseases | 2 | 2023 | 2113 | 0.200 |
Why?
|
Luminescent Proteins | 2 | 2020 | 887 | 0.200 |
Why?
|
Tissue Plasminogen Activator | 1 | 2007 | 1311 | 0.190 |
Why?
|
Cell Shape | 1 | 2020 | 379 | 0.180 |
Why?
|
Uveitis | 1 | 2023 | 408 | 0.180 |
Why?
|
Limbus Corneae | 1 | 2020 | 139 | 0.170 |
Why?
|
Receptors, Purinergic P2X2 | 1 | 2017 | 14 | 0.170 |
Why?
|
Suramin | 1 | 2017 | 36 | 0.170 |
Why?
|
Adoptive Transfer | 1 | 2021 | 874 | 0.170 |
Why?
|
Oxytocin | 1 | 2021 | 374 | 0.160 |
Why?
|
Muscle, Smooth | 1 | 2021 | 955 | 0.160 |
Why?
|
Magnetic Resonance Angiography | 3 | 2017 | 1469 | 0.160 |
Why?
|
Thrombolytic Therapy | 1 | 2007 | 2182 | 0.160 |
Why?
|
Fibrinolytic Agents | 1 | 2007 | 2139 | 0.150 |
Why?
|
Retinal Diseases | 1 | 2023 | 681 | 0.150 |
Why?
|
Muscle Contraction | 1 | 2021 | 1250 | 0.150 |
Why?
|
Eye | 1 | 2020 | 720 | 0.150 |
Why?
|
Coculture Techniques | 1 | 2020 | 1377 | 0.150 |
Why?
|
Thyrotoxicosis | 1 | 2016 | 81 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2018 | 4480 | 0.140 |
Why?
|
Corneal Neovascularization | 1 | 2017 | 204 | 0.140 |
Why?
|
Receptors, Proteinase-Activated | 1 | 2014 | 17 | 0.140 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2017 | 634 | 0.140 |
Why?
|
Kinetics | 2 | 2020 | 6805 | 0.140 |
Why?
|
Herpesvirus 1, Human | 1 | 2020 | 728 | 0.130 |
Why?
|
Adaptive Immunity | 1 | 2020 | 702 | 0.130 |
Why?
|
Retinal Ganglion Cells | 2 | 2018 | 772 | 0.130 |
Why?
|
Free Radicals | 1 | 2014 | 255 | 0.130 |
Why?
|
Moyamoya Disease | 1 | 2016 | 225 | 0.120 |
Why?
|
Protective Agents | 1 | 2014 | 165 | 0.120 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9927 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1038 | 0.120 |
Why?
|
Cell Hypoxia | 1 | 2014 | 684 | 0.110 |
Why?
|
Anti-Inflammatory Agents | 2 | 2014 | 1801 | 0.110 |
Why?
|
Chemotaxis | 1 | 2014 | 618 | 0.110 |
Why?
|
Nitric Oxide Synthase | 1 | 2014 | 939 | 0.110 |
Why?
|
Animals | 13 | 2023 | 170894 | 0.100 |
Why?
|
Graft Survival | 1 | 2021 | 3765 | 0.100 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22929 | 0.100 |
Why?
|
Down-Regulation | 1 | 2017 | 3094 | 0.090 |
Why?
|
Wound Healing | 1 | 2021 | 2800 | 0.090 |
Why?
|
Bacterial Proteins | 2 | 2020 | 4016 | 0.090 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18353 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2018 | 6529 | 0.090 |
Why?
|
Mice | 9 | 2023 | 81128 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2021 | 3433 | 0.090 |
Why?
|
Brain Stem Infarctions | 1 | 2008 | 31 | 0.080 |
Why?
|
Calcium | 1 | 2021 | 5832 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2020 | 3433 | 0.080 |
Why?
|
Mice, Inbred BALB C | 3 | 2021 | 6676 | 0.080 |
Why?
|
Cells, Cultured | 2 | 2021 | 20097 | 0.080 |
Why?
|
Herpesvirus 3, Human | 1 | 2008 | 219 | 0.080 |
Why?
|
Pons | 1 | 2008 | 253 | 0.080 |
Why?
|
Paresis | 1 | 2008 | 178 | 0.080 |
Why?
|
Angiography, Digital Subtraction | 1 | 2008 | 370 | 0.080 |
Why?
|
NF-kappa B | 1 | 2014 | 2584 | 0.070 |
Why?
|
Postpartum Period | 1 | 2012 | 982 | 0.070 |
Why?
|
Facial Nerve | 1 | 2008 | 276 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1948 | 0.070 |
Why?
|
Cerebrospinal Fluid | 1 | 2008 | 555 | 0.070 |
Why?
|
Cerebrovascular Disorders | 1 | 2012 | 1513 | 0.070 |
Why?
|
Cytokines | 1 | 2018 | 7223 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5814 | 0.060 |
Why?
|
Deglutition Disorders | 1 | 2008 | 578 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2007 | 2298 | 0.060 |
Why?
|
HIV Infections | 1 | 2008 | 15673 | 0.060 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2022 | 128 | 0.050 |
Why?
|
Receptor, Melanocortin, Type 1 | 1 | 2021 | 83 | 0.050 |
Why?
|
Neutrophils | 1 | 2014 | 3816 | 0.050 |
Why?
|
Blotting, Western | 2 | 2021 | 5438 | 0.050 |
Why?
|
Substance P | 1 | 2022 | 337 | 0.050 |
Why?
|
Humans | 15 | 2023 | 717280 | 0.050 |
Why?
|
Cell Line, Transformed | 1 | 2021 | 986 | 0.050 |
Why?
|
Ciliary Body | 1 | 2020 | 177 | 0.050 |
Why?
|
Iris | 1 | 2020 | 222 | 0.050 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2011 | 2122 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2021 | 1917 | 0.040 |
Why?
|
Choroid | 1 | 2020 | 315 | 0.040 |
Why?
|
Epithelium, Corneal | 1 | 2021 | 263 | 0.040 |
Why?
|
Signal Transduction | 1 | 2021 | 23997 | 0.040 |
Why?
|
Th1 Cells | 1 | 2022 | 1082 | 0.040 |
Why?
|
Optic Nerve | 1 | 2020 | 556 | 0.040 |
Why?
|
Conjunctiva | 1 | 2020 | 488 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2022 | 891 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2008 | 2797 | 0.040 |
Why?
|
Th17 Cells | 1 | 2022 | 753 | 0.030 |
Why?
|
Latin America | 1 | 2016 | 352 | 0.030 |
Why?
|
Mandible | 1 | 2020 | 728 | 0.030 |
Why?
|
Adult | 4 | 2017 | 212470 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2020 | 1301 | 0.030 |
Why?
|
Actins | 1 | 2021 | 2189 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2022 | 3277 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2220 | 0.030 |
Why?
|
Drug Combinations | 1 | 2017 | 1942 | 0.030 |
Why?
|
Florida | 1 | 2013 | 440 | 0.030 |
Why?
|
Male | 5 | 2021 | 351399 | 0.030 |
Why?
|
Female | 8 | 2021 | 377934 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2013 | 526 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 4846 | 0.030 |
Why?
|
Rabbits | 1 | 2017 | 5143 | 0.030 |
Why?
|
Pericytes | 1 | 2013 | 262 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2008 | 34503 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2023 | 4383 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39302 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3694 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2013 | 2022 | 0.020 |
Why?
|
Gene Expression | 1 | 2022 | 8013 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2012 | 607 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2012 | 959 | 0.020 |
Why?
|
Risk Factors | 2 | 2013 | 70863 | 0.020 |
Why?
|
Women's Health | 1 | 2016 | 1935 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2013 | 1489 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 15258 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 2012 | 1383 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2012 | 62344 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2012 | 1620 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11777 | 0.020 |
Why?
|
Up-Regulation | 1 | 2013 | 4356 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2012 | 1850 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10376 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1646 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 2012 | 2567 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4594 | 0.010 |
Why?
|
Child | 1 | 2007 | 74388 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12484 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2012 | 3009 | 0.010 |
Why?
|
African Americans | 1 | 2013 | 5025 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13605 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2012 | 2830 | 0.010 |
Why?
|
Registries | 1 | 2013 | 8095 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 14899 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7847 | 0.010 |
Why?
|
Rats | 1 | 2013 | 25092 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2016 | 72608 | 0.010 |
Why?
|
Pregnancy | 1 | 2012 | 27304 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20435 | 0.010 |
Why?
|
Young Adult | 1 | 2012 | 56249 | 0.000 |
Why?
|
Adolescent | 1 | 2012 | 85143 | 0.000 |
Why?
|
Aged | 1 | 2013 | 162862 | 0.000 |
Why?
|
Middle Aged | 1 | 2013 | 215054 | 0.000 |
Why?
|